SAT0166 An Analysis of Laboratory Results from 2 Randomized, Double-Blind Studies of Sirukumab in Patients with Active Rheumatoid Arthritis Refractory To Disease-Modifying Anti-Rheumatic Drug Treatment: Table 1.
Karpouzas, G., Thorne, C., Takeuchi, T., Tanaka, Y., Yamanaka, H., Harigai, M., Ota, T., Sheng, S., Xu, W., Xu, S., Kurrasch, R., Fei, K., Hsu, B.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.4126
Date:
June, 2016
File:
PDF, 88 KB
english, 2016